SAB Biotherapeutics, Inc. (SABSW) has a market capitalization of $238.95K and trades at $0.03. The 52-week range is 0.028-0.0477.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.1, Earnings Per Share (EPS) of $0.22.
The stock has a beta of 0.61, operates in the Healthcare sector.
